Jazz Pharmaceuticals plc
JAZZ
$138.81
$2.361.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.99B | 2.62B | 1.98B | 1.82B | 1.63B |
| Total Receivables | 716.77M | 723.64M | 698.04M | 707.10M | 705.79M |
| Inventory | 480.45M | 539.30M | 542.56M | 577.32M | 597.04M |
| Prepaid Expenses | 177.41M | 155.13M | 134.42M | 122.56M | 185.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 260.58M | 354.20M | 325.85M | 309.49M | 317.03M |
| Total Current Assets | 4.63B | 4.39B | 3.68B | 3.54B | 3.44B |
|
|
|||||
| Total Current Assets | 4.63B | 4.39B | 3.68B | 3.54B | 3.44B |
| Net Property, Plant & Equipment | 227.00M | 253.59M | 242.43M | 227.87M | 234.99M |
| Long-term Investments | 1.72B | 1.80B | 1.74B | 1.74B | 1.75B |
| Goodwill | 1.72B | 1.80B | 1.74B | 1.74B | 1.75B |
| Total Other Intangibles | 4.76B | 5.14B | 5.08B | 5.24B | 5.42B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 679.88M | 658.54M | 617.31M | 579.59M | 547.08M |
| Total Assets | 12.01B | 12.26B | 11.36B | 11.33B | 11.39B |
|
|
|||||
| Total Accounts Payable | 77.87M | 85.43M | 97.10M | 80.98M | 102.75M |
| Total Accrued Expenses | 821.98M | 805.32M | 749.07M | 778.62M | 748.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.78M | 50.10M | 622.95M | 623.73M | 624.40M |
| Total Finance Division Other Current Liabilities | 92.94M | 89.13M | 86.91M | 78.87M | 61.33M |
| Total Other Current Liabilities | 92.94M | 89.13M | 86.91M | 78.87M | 61.33M |
| Total Current Liabilities | 1.04B | 1.03B | 1.56B | 1.56B | 1.54B |
|
|
|||||
| Total Current Liabilities | 1.04B | 1.03B | 1.56B | 1.56B | 1.54B |
| Long-Term Debt | 6.08B | 6.08B | 5.10B | 5.11B | 5.11B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.50M | 71.12M | 67.62M | 56.16M | 64.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 758.79M | 900.35M | 874.64M | 907.14M | 944.01M |
| Total Liabilities | 7.92B | 8.08B | 7.60B | 7.63B | 7.66B |
|
|
|||||
| Common Stock & APIC | 3.91B | 3.84B | 3.78B | 3.71B | 3.70B |
| Retained Earnings | 1.13B | 936.23M | 871.18M | 864.04M | 878.66M |
| Treasury Stock & Other | -947.14M | -602.87M | -887.70M | -881.87M | -841.62M |
| Total Common Equity | 4.09B | 4.17B | 3.76B | 3.70B | 3.74B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.09B | 4.17B | 3.76B | 3.70B | 3.74B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.09B | 4.17B | 3.76B | 3.70B | 3.74B |
|
|
|||||
